Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Reading Level
      Reading Level
      Clear All
      Reading Level
  • Content Type
      Content Type
      Clear All
      Content Type
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
      More Filters
      Clear All
      More Filters
      Item Type
    • Is Full-Text Available
    • Subject
    • Publisher
    • Source
    • Donor
    • Language
    • Place of Publication
    • Contributors
    • Location
3 result(s) for "Uecke, Oliver"
Sort by:
Clinical trials: Considerations for researchers and hospital administrators
Background: Clinical studies play a pivotal role in the development of new pharmaceutical drugs. Before newly developed active substances can be put on the market the law requires that they be tested in a large number of clinical trials. The initiators of these trials are usually study groups (publicly funded trials) or the pharmaceutical industry, which often supplies the drugs for clinical research in hospitals. There is reason to believe that hospital administrators could make cost savings on drugs. Purpose: The purpose of this article is t o quantify drug cost savings in hospitals related t o clinical trials and t o examine the relationship between researchers and hospital administrators with respect t o clinical trials. Methodology/Approach: We analyzed 88 clinical trials in oncology including 29 researchers in 11 hospitals in Germany from 2002 through 2005. We also interviewed researchers and hospital administrators concerning their attitude toward these clinical trials. We propose that hospital administrators tend t o focus on the economics of conducting clinical trials. Findings: The results showed a drug cost saving potential of US $6.7 million (€5.1 million) in 11 hospitals from 2002 through 2005 and an actual cost saving of US $2.0 million (€1.5 million). The hospital administrators underestimated the difficulties that researchers experienced because of lack of personnel resources when conducting clinical trials. Practice Implications: The hospital administrator has a financial incentive to provide internal conditions in the hospital that facilitate incentives for researchers to become involved in clinical trials. We suggest supporting researchers actively in research with additional human resources (study nurses, etc.). We propose that this would result in a higher number of patients taking part and in more clinical trials. Consequently, higher drug cost savings could also be realized.
Best practices for developing university bioentrepreneurship education programmes
The objective of this paper is to present a comprehensive overview on the bioentrepreneurship education programme organised within the framework of the project ‘Technological Entrepreneurship at the Free University of Brussels (Vrije Universiteit Brussel, VUB)’. The main motivations for implementing this high-technology entrepreneurship education programme are the threats posed by the low entrepreneurial activity in Belgium and by the European innovation paradox. The biotechnology programme was implemented to stimulate and teach bioentrepreneurship among master students in business and bio-engineering at the university. The theoretical background of the paper focuses on entrepreneurship education in an academic environment and relating success factors to discover possible solutions. Following this, the paper presents a case study on the bioentrepreneurship programme implemented at the VUB. The main objective of the project is to develop and implement a set of integrated, interdisciplinary courses, organised by different faculties and attended by students in business and in bio-engineering. By presenting this solution and showing that it is possible to implement an interdisciplinary educational programme on bioentrepreneurship in a university environment, the authors suggest increasing the number of such programmes across European universities.